Merck To Pay Billions For Cubist Pharmaceuticals

Merck Pharmaceuticals is ready to write a huge check for the acquisition of Cubist Pharmaceuticals Incorporated. Cubist Pharmaceuticals is known for advanced antibiotic research. Despite layoffs and buyouts of its workforce over the last several years, Merck is in the buying mood and will pay 8.4 billion dollars for Cubist. Merck owns a facility in Upper Gwynedd Township on Sumneytown Pike.